Real World Data Analysis: Impact of High-Frequency REN Treatments As Migraine Preventive Therapy in Adolescence

CompletedOBSERVATIONAL
Enrollment

83

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

April 15, 2023

Study Completion Date

May 1, 2023

Conditions
Migraine
Interventions
DEVICE

Nerivio

Remote electrical neuromodulation (REN) device for the acute treatment of migraines. The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. The treatment is self-administered and controlled by a smartphone application.

Trial Locations (1)

08807

Theranica USA Inc, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theranica

INDUSTRY

NCT05769322 - Real World Data Analysis: Impact of High-Frequency REN Treatments As Migraine Preventive Therapy in Adolescence | Biotech Hunter | Biotech Hunter